Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from CSPC Pharmaceutical Group ( (HK:1093) ).
CSPC Pharmaceutical Group Limited announced the resignation of Mr. PAN Weidong as Executive Director and his replacement as the Authorized Representative by Dr. LI Chunlei. This change is part of the company’s ongoing management adjustments, which may influence its strategic direction and operational focus.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.
Average Trading Volume: 165,026,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$88.46B
Learn more about 1093 stock on TipRanks’ Stock Analysis page.